These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1436 related items for PubMed ID: 12325038

  • 1. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma.
    Zhang YJ, Ahsan H, Chen Y, Lunn RM, Wang LY, Chen SY, Lee PH, Chen CJ, Santella RM.
    Mol Carcinog; 2002 Oct; 35(2):85-92. PubMed ID: 12325038
    [Abstract] [Full Text] [Related]

  • 2. Frequent epigenetic silencing of the CpG island promoter of RASSF1A in thyroid carcinoma.
    Schagdarsurengin U, Gimm O, Hoang-Vu C, Dralle H, Pfeifer GP, Dammann R.
    Cancer Res; 2002 Jul 01; 62(13):3698-701. PubMed ID: 12097277
    [Abstract] [Full Text] [Related]

  • 3. Frequent epigenetic inactivation of the RASSF1A gene in hepatocellular carcinoma.
    Schagdarsurengin U, Wilkens L, Steinemann D, Flemming P, Kreipe HH, Pfeifer GP, Schlegelberger B, Dammann R.
    Oncogene; 2003 Mar 27; 22(12):1866-71. PubMed ID: 12660822
    [Abstract] [Full Text] [Related]

  • 4. Intensive hypermethylation of the CpG island of Ras association domain family 1A in hepatitis B virus-associated hepatocellular carcinomas.
    Zhong S, Yeo W, Tang MW, Wong N, Lai PB, Johnson PJ.
    Clin Cancer Res; 2003 Aug 15; 9(9):3376-82. PubMed ID: 12960125
    [Abstract] [Full Text] [Related]

  • 5. Frequent epigenetic inactivation of RASSF1A by aberrant promoter hypermethylation in human gastric adenocarcinoma.
    Byun DS, Lee MG, Chae KS, Ryu BG, Chi SG.
    Cancer Res; 2001 Oct 01; 61(19):7034-8. PubMed ID: 11585730
    [Abstract] [Full Text] [Related]

  • 6. The CpG island of the novel tumor suppressor gene RASSF1A is intensely methylated in primary small cell lung carcinomas.
    Dammann R, Takahashi T, Pfeifer GP.
    Oncogene; 2001 Jun 14; 20(27):3563-7. PubMed ID: 11429703
    [Abstract] [Full Text] [Related]

  • 7. Frequent epigenetic inactivation of RASSF1A in human bladder carcinoma.
    Lee MG, Kim HY, Byun DS, Lee SJ, Lee CH, Kim JI, Chang SG, Chi SG.
    Cancer Res; 2001 Sep 15; 61(18):6688-92. PubMed ID: 11559536
    [Abstract] [Full Text] [Related]

  • 8. [Aberrant methylation of multiple genes and its clinical implication in hepatocellular carcinoma].
    Lou C, Yang B, Gao YT, Wang YJ, Nie FH, Yuan Q, Zhang CL, Du Z.
    Zhonghua Zhong Liu Za Zhi; 2008 Nov 15; 30(11):831-6. PubMed ID: 19173828
    [Abstract] [Full Text] [Related]

  • 9. CpG island methylator phenotype association with elevated serum alpha-fetoprotein level in hepatocellular carcinoma.
    Zhang C, Li Z, Cheng Y, Jia F, Li R, Wu M, Li K, Wei L.
    Clin Cancer Res; 2007 Feb 01; 13(3):944-52. PubMed ID: 17289889
    [Abstract] [Full Text] [Related]

  • 10. Epigenetic inactivation of RAS association domain family protein 1 (RASSF1A) in malignant cutaneous melanoma.
    Spugnardi M, Tommasi S, Dammann R, Pfeifer GP, Hoon DS.
    Cancer Res; 2003 Apr 01; 63(7):1639-43. PubMed ID: 12670917
    [Abstract] [Full Text] [Related]

  • 11. Large-scale analysis of the genetic and epigenetic alterations in hepatocellular carcinoma from Southeast China.
    Su H, Zhao J, Xiong Y, Xu T, Zhou F, Yuan Y, Zhang Y, Zhuang SM.
    Mutat Res; 2008 May 10; 641(1-2):27-35. PubMed ID: 18358501
    [Abstract] [Full Text] [Related]

  • 12. The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14(ARF), p16(INK4a) and RASSF1A in human lung cancer cell lines.
    Sato M, Horio Y, Sekido Y, Minna JD, Shimokata K, Hasegawa Y.
    Oncogene; 2002 Jul 18; 21(31):4822-9. PubMed ID: 12101420
    [Abstract] [Full Text] [Related]

  • 13. Hypermethylation of the cpG island of Ras association domain family 1A (RASSF1A), a putative tumor suppressor gene from the 3p21.3 locus, occurs in a large percentage of human breast cancers.
    Dammann R, Yang G, Pfeifer GP.
    Cancer Res; 2001 Apr 01; 61(7):3105-9. PubMed ID: 11306494
    [Abstract] [Full Text] [Related]

  • 14. Frequent hypermethylation of the RASSF1A gene in prostate cancer.
    Liu L, Yoon JH, Dammann R, Pfeifer GP.
    Oncogene; 2002 Oct 03; 21(44):6835-40. PubMed ID: 12360410
    [Abstract] [Full Text] [Related]

  • 15. Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing.
    Gonzalez-Zulueta M, Bender CM, Yang AS, Nguyen T, Beart RW, Van Tornout JM, Jones PA.
    Cancer Res; 1995 Oct 15; 55(20):4531-5. PubMed ID: 7553622
    [Abstract] [Full Text] [Related]

  • 16. Frequent RASSF1A promoter hypermethylation and K-ras mutations in pancreatic carcinoma.
    Dammann R, Schagdarsurengin U, Liu L, Otto N, Gimm O, Dralle H, Boehm BO, Pfeifer GP, Hoang-Vu C.
    Oncogene; 2003 Jun 12; 22(24):3806-12. PubMed ID: 12802288
    [Abstract] [Full Text] [Related]

  • 17. Clinicopathological significance of epigenetic inactivation of RASSF1A at 3p21.3 in stage I lung adenocarcinoma.
    Tomizawa Y, Kohno T, Kondo H, Otsuka A, Nishioka M, Niki T, Yamada T, Maeshima A, Yoshimura K, Saito R, Minna JD, Yokota J.
    Clin Cancer Res; 2002 Jul 12; 8(7):2362-8. PubMed ID: 12114441
    [Abstract] [Full Text] [Related]

  • 18. Methylation framework of cell cycle gene inhibitors in cirrhosis and associated hepatocellular carcinoma.
    Roncalli M, Bianchi P, Bruni B, Laghi L, Destro A, Di Gioia S, Gennari L, Tommasini M, Malesci A, Coggi G.
    Hepatology; 2002 Aug 12; 36(2):427-32. PubMed ID: 12143052
    [Abstract] [Full Text] [Related]

  • 19. RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours.
    Astuti D, Agathanggelou A, Honorio S, Dallol A, Martinsson T, Kogner P, Cummins C, Neumann HP, Voutilainen R, Dahia P, Eng C, Maher ER, Latif F.
    Oncogene; 2001 Nov 08; 20(51):7573-7. PubMed ID: 11709729
    [Abstract] [Full Text] [Related]

  • 20. Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma.
    Kwong J, Lo KW, To KF, Teo PM, Johnson PJ, Huang DP.
    Clin Cancer Res; 2002 Jan 08; 8(1):131-7. PubMed ID: 11801549
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 72.